canrenoic acid has been researched along with aldosterone in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (59.02) | 18.7374 |
1990's | 9 (14.75) | 18.2507 |
2000's | 11 (18.03) | 29.6817 |
2010's | 5 (8.20) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Claire, M; Corvol, P; Menard, J; Michaud, A; Rafestin-Oblin, ME; Roth-Meyer, C | 1 |
Kudisov, IuM; Razumova, ET; Rossel's, AN; Sidorenko, BA | 1 |
Armanini, D; Fallo, F; Mantero, F; Opocher, G | 1 |
Ferguson, DR; James, PS; Paterson, JY; Saunders, JC; Smith, MW | 1 |
Landais, P; Mavoungou, D; Murakami, T; Nowaczynski, M; Nowaczynski, W; Vitullo, B | 1 |
Corvol, P; Delarue, C; Jegou, S; Kusmierek, MC; Leboulenger, F; Leroux, P; Tonon, MC; Vaillant, R; Vaudry, H | 1 |
Casals-Stenzel, J; Losert, W; Schmalbach, J | 1 |
Brass, B; Mertin, J; Simon, O | 1 |
Kim, KS; Miyamori, I; Morimoto, S; Takeda, R; Uchida, K; Yamamoto, I | 1 |
Aupetit, B; Duchier, J; Legrand, JC | 1 |
Cheng, SC; Harding, BW; Sadee, W; Suzuki, K | 1 |
Bie, P | 1 |
Baethmann, A; Finn, AM; Sadée, W; Schmiedek, P | 1 |
Brown, JA; Garland, HO; Henderson, IW | 1 |
Hofmann, LM; Maibach, HI; Polk, RC | 1 |
Consolo, F; Ferraù, O; Luzza, G; Pitrone, F; Russo, A; Virga, T | 1 |
Käsmayr, J; Theisen, K; Wehling, M | 2 |
Mori, N; Sakai, S; Uozumi, N; Yura, K | 1 |
Nakazawa, S; Node, Y | 1 |
Hoashi, S; Honda, N; Ikebe, H; Irie, F; Kobayashi, N; Mitarai, Y; Taniguchi, K | 1 |
Cuppone, R; Emili, M; Ricci, GL | 1 |
Brem, AS; Morris, DJ; Pacholski, M | 1 |
Ozaki, N; Suzuki, S; Takamura, S; Yoshida, J | 1 |
Kiyose, H; Nagano, M; Tagawa, H; Tanaka, S; Umezu, M; Yamakado, M | 1 |
Boer, P; Dorhout Mees, EJ; Hené, RJ; Koomans, HA | 1 |
Brem, AS; Freiberger, M; Latif, SA; McDermott, MJ; Morris, DJ; Pacholski, M | 1 |
Buse, M; Casals-Stenzel, J; Losert, W | 1 |
Rabinowitz, L; Sarason, RL; Yamauchi, H | 2 |
Freiberger, M; Latif, SA; McDermott, MJ; Morris, DJ | 1 |
Capron, MH; Delarue, C; Kusmierek, MC; Leboulenger, F; Netchitailo, P; Perroteau, I; Roullet, M; Vaudry, H | 1 |
Dubach, UC; Kaissling, B; Le Hir, M | 1 |
Apostolopoulou, K; Lasaridis, AN; Pharmakiotis, A; Spanos, P; Tourkantonis, A | 1 |
Fanti, P; Mantellini, R; Sciarra, F; Tosti-Croce, C | 1 |
Budaj, A; Ceremuzyński, L; Michorowski, B | 1 |
Latif, SA; McDermott, MJ; Morris, DJ | 1 |
Claire, M; Corvol, P; Geering, K; Oblin, ME; Rossier, B | 1 |
Liebich, HG; Mertin, J; Seifert, J | 1 |
Haschke, F; Parth, K; Wimmer, M | 1 |
Albino, G; Angeli, P; Caregaro, L; Ceolotto, G; Dalla Pria, M; De Bei, E; Gatta, A; Merkel, C | 1 |
Boer, P; Koomans, HA; van Buren, M | 1 |
Mori, N; Nario, K; Sakai, S; Yura, K | 1 |
Funder, JW; Young, MJ | 1 |
Blaehr, H; Dahl, HB; Egfjord, M; Kayser, C | 1 |
Brazzarola, P; Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C | 1 |
Ogawa, R; Watanabe, T | 1 |
Arvat, E; Broglio, F; Camanni, F; Ghigo, E; Gianotti, L; Giordano, R; Maccagno, B; Maccario, M; Pellegrino, M | 1 |
Remme, WJ | 1 |
Arias, C; Caballero, R; Delpón, E; González, T; Moreno, I; Tamargo, J; Valenzuela, C | 1 |
Bendtzen, K; Hansen, PR; Rieneck, K | 1 |
Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM | 1 |
Feuring, M; Horisberger, K; Schmidt, BM; Schultz, A; Wehling, M | 1 |
Albiger, N; Armanini, D; Fiore, C; Mattarello, MJ; Sartorato, P; Scaroni, C | 1 |
Beugels, IP; Cohuet, GM; de Gooyer, ME; Emmen, JM; Hermans, JJ; Hilbers, PA; Minnaard-Huiban, M; Ottenheijm, HC; Pieterse, K; Plate, R; Roumen, L; Ruijters, E; Smits, JF; van Essen, H | 1 |
Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D | 1 |
Chai, W; Danser, AH; de Jong, FH; de Vries, R; Feelders, RA; Garrelds, IM; Hofland, J; Jansen, PM; van den Bogaerdt, AJ | 1 |
Bowalgaha, K; Knights, KM; Miners, JO | 1 |
Beygui, F; Ecollan, P; Machecourt, J; Montalescot, G; Van Belle, E; Vicaut, E; Zannad, F | 1 |
Adler, GK; Coutinho, P; Maldonado, ER; Pojoga, LH; Rivera, A; Romero, JR; Turchin, A; Williams, GH; Williams, J; Yao, TM; Youte, R | 1 |
Brochu, M; Houde, V; Provencher, M; St-Louis, J | 1 |
2 review(s) available for canrenoic acid and aldosterone
Article | Year |
---|---|
Spirolactones: clinical and pharmacologic studies.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldosteronism; Hypertension; In Vitro Techniques; Kidney; Mineralocorticoid Receptor Antagonists; Pregnadienes; Protein Binding; Rats; Receptors, Cell Surface; Spironolactone | 1977 |
Mechanism of the antimineralocorticoid effects of spirolactones.
Topics: Aldosterone; Animals; Anura; Canrenoic Acid; Canrenone; Cattle; Guinea Pigs; Humans; Male; Mineralocorticoid Receptor Antagonists; Rats; Receptors, Steroid; Spironolactone; Veratrum Alkaloids | 1981 |
9 trial(s) available for canrenoic acid and aldosterone
Article | Year |
---|---|
[Use of the aldosterone antagonist, canrenoate potassium for treating chronic circulatory insufficiency].
Topics: Adult; Aged; Aldosterone; Canrenoic Acid; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Digoxin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pregnadienes; Pulmonary Heart Disease; Rheumatic Heart Disease; Water-Electrolyte Balance | 1979 |
Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
Topics: Aldosterone; Canrenoic Acid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperaldosteronism; Liver Cirrhosis; Liver Function Tests; Male; Pregnadienes; Random Allocation; Spironolactone | 1988 |
[Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
Topics: Administration, Oral; Adult; Aldosterone; Blood Pressure; Canrenoic Acid; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pregnadienes; Renin; Spironolactone; Time Factors | 1983 |
Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Amiloride; Ascites; Canrenoic Acid; Female; Humans; Kidney Tubules, Proximal; Liver Cirrhosis; Male; Middle Aged; Renin-Angiotensin System; Sodium; Uremia | 1994 |
Suppression of surgical hyperaldosteronism by potassium canrenoate during gynecologic surgery under sevoflurane anesthesia.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Anesthesia, Inhalation; Anesthetics, Inhalation; Blood Pressure; Canrenoic Acid; Female; Gynecologic Surgical Procedures; Humans; Hyperaldosteronism; Intraoperative Complications; Male; Methyl Ethers; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sevoflurane; Sodium | 2000 |
Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Arginine Vasopressin; Canrenoic Acid; Corticotropin-Releasing Hormone; Dehydroepiandrosterone; Feedback; Female; Humans; Hydrocortisone; Kinetics; Mineralocorticoid Receptor Antagonists; Placebos; Receptors, Mineralocorticoid | 2001 |
Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism.
Topics: Adult; Aldosterone; Baroreflex; Blood Pressure; Canrenoic Acid; Cross-Over Studies; Double-Blind Method; Humans; Kinetics; Male; Mineralocorticoid Receptor Antagonists; Placebos | 2005 |
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.
Topics: Adult; Aldosterone; Blood Pressure; Canrenoic Acid; Electrolytes; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System | 2005 |
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial.
Topics: Aged; Aldosterone; Canrenoic Acid; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Treatment Outcome | 2010 |
50 other study(ies) available for canrenoic acid and aldosterone
Article | Year |
---|---|
[Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
Topics: Adolescent; Adult; Aldosterone; Canrenoic Acid; Female; Humans; Hypertension; Male; Middle Aged; Pregnadienes; Renin | 1978 |
Aldosterone induced changes in colonic sodium transport occurring naturally during development in the neonatal pig.
Topics: Aging; Aldosterone; Animals; Animals, Newborn; Biological Transport; Canrenoic Acid; Colon; Membrane Potentials; Sodium; Swine | 1979 |
Genetic aspects of plasma aldosterone binding globulins in families of patients with essential hypertension, including isolation of novel thermostable homologues from plasma and urine.
Topics: Adolescent; Adult; Aged; Aldosterone; Canrenoic Acid; Carrier Proteins; Child; Child, Preschool; Female; Humans; Hypertension; Male; Middle Aged; Pedigree; Serum Globulins | 1979 |
Comparative effects of canrenoate-K and prorenoate-K upon aldosterone biosynthesis in perifused frog interrenal glands.
Topics: Adrenal Glands; Aldosterone; Animals; Anura; Canrenoic Acid; Interrenal Gland; Mineralocorticoid Receptor Antagonists; Pregnadienes; Radioimmunoassay; Ranidae; Spironolactone; Time Factors | 1979 |
Improved method for comparative evaluation of aldosterone antagonists in healthy man.
Topics: Adult; Aldosterone; Canrenoic Acid; Drug Evaluation; Female; Humans; Male; Mineralocorticoid Receptor Antagonists; Potassium; Sodium; Spironolactone; Time Factors | 1977 |
[EEG changes following spirolactone treatment (author's transl)].
Topics: Aldosterone; Brain Edema; Canrenoic Acid; Electroencephalography; Encephalitis; Female; Humans; Male; Multiple Sclerosis; Spironolactone | 1978 |
[Measurement of plasma aldosterone by 125I-aldosterone radioimmunoassay kit (author's transl)].
Topics: Aldosterone; Animals; Canrenoic Acid; Cross Reactions; Humans; Radioimmunoassay; Rats; Reagent Kits, Diagnostic; Spironolactone | 1978 |
[Effect of spironolactones on aldosterone synthesis and adrenal metabolism].
Topics: Adrenal Glands; Aldosterone; Animals; Canrenoic Acid; Canrenone; Ducks; Hydroxylation; Mineralocorticoid Receptor Antagonists; Mitochondria; Mitochondria, Liver; Oxidative Phosphorylation; Sheep; Spironolactone; Steroid Hydroxylases | 1978 |
Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Animals; Canrenoic Acid; Canrenone; Cattle; Cytochrome P-450 Enzyme System; Humans; Hyperplasia; Mitochondria; Oxidation-Reduction; Pregnadienes; Spectrum Analysis; Spironolactone; Steroid Hydroxylases | 1976 |
Sodium excretion and sodium-free volume expansion in dogs: effect of inhibition of aldosterone activity by canrenoate.
Topics: Aldosterone; Animals; Canrenoic Acid; Diuresis; Dogs; Female; Natriuresis; Pregnadienes; Renin; Sodium | 1976 |
Aldosterone plasma radioimmunoassay interference by a spirolactone metabolite.
Topics: Aldosterone; Animals; Canrenoic Acid; Cross Reactions; Dogs; Humans; Mass Spectrometry; Pregnadienes; Rabbits; Radioimmunoassay; Species Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spironolactone; Time Factors | 1975 |
Micropuncture study of the renal responses of the urodele amphibian Necturus maculosus to injections of arginine vasotocin and an anti-aldosterone compound.
Topics: Aldosterone; Amphibians; Animals; Calcium; Canrenoic Acid; Female; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Kidney Glomerulus; Kidney Tubules; Male; Mineralocorticoid Receptor Antagonists; Osmolar Concentration; Potassium; Regional Blood Flow; Sodium; Vasotocin; Vitamin B 12; Water | 1975 |
Renal clearance of canrenoate in normal man.
Topics: 17-Ketosteroids; Aldosterone; Canrenoic Acid; Canrenone; Humans; Hydroxysteroids; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Pregnadienes; Renin | 1975 |
[Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
Topics: Adult; Aged; Aldosterone; Canrenoic Acid; Electrolytes; Female; Humans; Hypertension; Male; Middle Aged; Pregnadienes; Renin | 1975 |
Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway?
Topics: Aldosterone; Calcium; Canrenoic Acid; Canrenone; Carrier Proteins; Dexamethasone; DNA; Humans; Hydrocortisone; In Vitro Techniques; Kinetics; Leukocytes, Mononuclear; Models, Biological; Potassium; Propionates; Reference Values; Sodium; Sodium-Hydrogen Exchangers | 1991 |
Effect of aldosterone antagonist on the DC potential in the endolymphatic sac.
Topics: Aldosterone; Animals; Canrenoic Acid; Endolymphatic Sac; Guinea Pigs; Membrane Potentials | 1991 |
Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Calcium; Canrenoic Acid; Canrenone; Corticosterone; Cycloheximide; Dactinomycin; Humans; Hydrocortisone; Leukocytes, Mononuclear; Middle Aged | 1990 |
Clinical study of potassium canrenoate on raised intracranial pressure.
Topics: Aldosterone; Brain Neoplasms; Canrenoic Acid; Humans; Intracranial Aneurysm; Intracranial Pressure; Pregnadienes | 1990 |
[Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
Topics: Aldosterone; Anesthesia, Epidural; Canrenoic Acid; Humans; Liver Cirrhosis; Potassium; Pregnadienes; Renin; Sodium | 1988 |
Time-dependent aldosterone metabolism in toad urinary bladder.
Topics: Aldosterone; Animals; Bufo marinus; Canrenoic Acid; Chromatography, High Pressure Liquid; In Vitro Techniques; Kinetics; Sodium; Tritium; Urinary Bladder | 1988 |
Effect of aldosterone antagonists on aldosterone-induced activation of Mg2+ -HCO3- -ATPase and carbonic anhydrase in rat intestinal mucosa.
Topics: Adenosine Triphosphatases; Adrenalectomy; Aldosterone; Animals; Ca(2+) Mg(2+)-ATPase; Canrenoic Acid; Carbonic Anhydrases; Dactinomycin; Duodenum; Enzyme Activation; Intestinal Mucosa; Jejunum; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Spironolactone | 1985 |
Extrarenal role of aldosterone in the regulation of blood pressure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension, Renovascular; Kidney; Middle Aged; Vascular Resistance; Vasoconstriction | 1988 |
Adaptation to chronic potassium loading in normal man.
Topics: Acetazolamide; Adaptation, Biological; Administration, Oral; Adult; Aldosterone; Body Weight; Canrenoic Acid; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney Tubules; Male; Potassium; Renin; Spironolactone; Time Factors | 1986 |
The effects of antimineralocorticoids on synthesis of aldosterone metabolites in target tissues.
Topics: Aldosterone; Animals; Bufonidae; Canrenoic Acid; Corticosterone; In Vitro Techniques; Kidney; Male; Mineralocorticoid Receptor Antagonists; Progesterone; Rats; Tritium; Urinary Bladder | 1986 |
Progestogens with antimineralocorticoid activity.
Topics: Adrenalectomy; Aldosterone; Androstadienes; Androstenes; Animals; Canrenoic Acid; Canrenone; Cyproterone; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Norethindrone; Norgestrel; Norpregnenes; Potassium; Progesterone; Progesterone Congeners; Rats; Rats, Inbred Strains; Sodium; Spironolactone | 1985 |
Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep.
Topics: Aldosterone; Animals; Canrenoic Acid; Female; Homeostasis; Kidney; Mineralocorticoid Receptor Antagonists; Potassium; Potassium Chloride; Sheep; Sodium | 1985 |
The synthesis of reduced metabolites of aldosterone by subcellular fractions of rat kidney: effects of antimineralocorticoids.
Topics: Aldosterone; Animals; Canrenoic Acid; Chromatography, High Pressure Liquid; Corticosterone; In Vitro Techniques; Kidney; Male; Mineralocorticoids; Progesterone; Rats; Rats, Inbred Strains | 1985 |
In vitro study of frog (Rana ridibunda Pallas) interrenal function by use of a simplified perifusion system-VI. Inhibition of aldosterone biosynthesis by SC 14266.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Canrenoic Acid; In Vitro Techniques; Male; Perfusion; Pregnadienes; Rana ridibunda; Receptors, Steroid | 1981 |
Distal tubular segments of the rabbit kidney after adaptation to altered Na- and K-intake. II. Changes in Na-K-ATPase activity.
Topics: Adaptation, Physiological; Aldosterone; Animals; Canrenoic Acid; Desoxycorticosterone; Diet; Diet, Sodium-Restricted; Female; Kidney Tubules; Kidney Tubules, Collecting; Kidney Tubules, Distal; Potassium; Rabbits; Sodium; Sodium-Potassium-Exchanging ATPase | 1982 |
The effects of canrenoate K on corticosteroid biosynthesis in nephrectomized dogs.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Canrenoic Acid; Dogs; Hydrocortisone; In Vitro Techniques; Kinetics; Nephrectomy; Pregnadienes; Renin | 1984 |
Sheep renal potassium excretion: efferent kaliuretic regulatory factors.
Topics: Aldosterone; Animals; Canrenoic Acid; Female; Infusions, Parenteral; Mineralocorticoid Receptor Antagonists; Potassium; Potassium Chloride; Potassium Deficiency; Sheep; Sodium | 1984 |
Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation.
Topics: Aged; Aldosterone; Canrenoic Acid; Diuresis; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Pregnadienes; Time Factors | 1983 |
The effects of adrenal and gonadal steroids and K+-canrenoate on the metabolism of aldosterone by rat liver microsomes.
Topics: Aldosterone; Animals; Canrenoic Acid; Chromatography, High Pressure Liquid; Corticosterone; Cytochrome P-450 Enzyme System; Estradiol; Gonadal Steroid Hormones; Male; Microsomes, Liver; Pregnadienes; Progesterone; Rats; Rats, Inbred Strains; Testosterone | 1983 |
[Changes in lymphocytes caused by aldosterone and a spironolactone derivative. Animal experiments and clinical studies].
Topics: Adult; Aldosterone; Animals; Canrenoic Acid; Female; Humans; Lymphocytes; Microscopy, Electron; Pregnadienes; Rats; Rats, Inbred Strains; Spironolactone | 1982 |
Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
Topics: Adolescent; Aldosterone; Canrenoic Acid; Child; Child, Preschool; Heart Defects, Congenital; Hematocrit; Humans; Hyperaldosteronism; Infant; Mineralocorticoid Receptor Antagonists; Postoperative Complications; Potassium; Sodium; Spironolactone | 1981 |
Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans.
Topics: Administration, Oral; Adult; Aldosterone; Analysis of Variance; Canrenoic Acid; Diuresis; Glucocorticoids; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Mifepristone; Mineralocorticoids; Potassium; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Sodium | 1993 |
Effect of intravenously applied canrenoate on ampullar endolymphatic potential.
Topics: Aldosterone; Animals; Canrenoic Acid; Dose-Response Relationship, Drug; Electrophysiology; Endolymph; Guinea Pigs; Infusions, Intravenous; Mineralocorticoid Receptor Antagonists; Semicircular Canals | 1995 |
The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
Topics: Aldosterone; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Canrenoic Acid; Cardiomegaly; Collagen; Corticosterone; Epithelium; Fibrosis; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Tetrazoles | 1996 |
Aldosterone metabolism in cultures of rat renal cortical and medullary cells.
Topics: Aldosterone; Animals; Canrenoic Acid; Carbon Radioisotopes; Cells, Cultured; Chromatography, High Pressure Liquid; Female; Kidney Cortex; Kidney Medulla; Liver; Mifepristone; Rats; Rats, Wistar; Receptors, Glucocorticoid | 1999 |
Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis.
Topics: Adult; Aldosterone; Antiporters; Calcium; Canrenoic Acid; Case-Control Studies; Female; Homeostasis; Humans; Hyperaldosteronism; In Vitro Techniques; Lymphocytes; Magnesium; Magnesium Deficiency; Male; Middle Aged; Mineralocorticoid Receptor Antagonists | 2000 |
Aldosterone and myocardial infarction--are aldosterone antagonists needed to prevent remodelling or does ACE inhibition suffice?
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Canrenoic Acid; Captopril; Cardiomegaly; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Peptidyl-Dipeptidase A | 2001 |
Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Topics: Aldosterone; Animals; Canrenoic Acid; Cation Transport Proteins; CHO Cells; Cricetinae; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Humans; Membrane Potentials; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Voltage-Gated; Spironolactone; Trans-Activators; Transcriptional Regulator ERG; Transfection | 2003 |
Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.
Topics: Aldosterone; Canrenoic Acid; Cells, Cultured; Cyproterone Acetate; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Lipopolysaccharides; Phytohemagglutinins; Pregnadienes; RNA, Messenger; Spironolactone; Transcription, Genetic | 2004 |
Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
Topics: Adrenergic beta-Agonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Canrenoic Acid; Fibrosis; Heart Failure; Isoproterenol; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2005 |
Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone.
Topics: Aldosterone; Animals; Canrenoic Acid; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Drug Evaluation, Preclinical; Fadrozole; Fibrosis; Gene Expression Regulation; Heart; Heart Failure; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Treatment Outcome | 2008 |
Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Female; Humans; Hypertension; Male; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Renin; Verapamil | 2008 |
Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Animals; Base Sequence; Canrenoic Acid; Child; Child, Preschool; Corticosterone; DNA Primers; Female; Gene Expression; Heart; Hemodynamics; Hormone Antagonists; Humans; In Vitro Techniques; Male; Middle Aged; Mifepristone; Myocardium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Steroids; Young Adult | 2010 |
Spironolactone and canrenone inhibit UGT2B7-catalyzed human liver and kidney microsomal aldosterone 18beta-glucuronidation: a potential drug interaction.
Topics: Aldosterone; Binding, Competitive; Canrenoic Acid; Canrenone; Drug Interactions; Glucuronosyltransferase; Humans; Hymecromone; In Vitro Techniques; Kidney; Microsomes; Microsomes, Liver; Spironolactone | 2010 |
Activation of the mineralocorticoid receptor increases striatin levels.
Topics: Aldosterone; Angiotensin II; Animals; Aorta; Calmodulin-Binding Proteins; Canrenoic Acid; Cells, Cultured; Diet, Sodium-Restricted; Endothelial Cells; Enzyme Inhibitors; Humans; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Myocardium; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Receptors, Mineralocorticoid | 2012 |
Mineralocorticoids participate in the reduced vascular reactivity of pregnant rats.
Topics: Aldosterone; Animals; Aorta, Thoracic; Benzimidazoles; Calcium Channel Blockers; Canrenoic Acid; Cromakalim; Female; KATP Channels; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Potassium Channels, Calcium-Activated; Potassium Chloride; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Vasoconstrictor Agents; Vasodilator Agents | 2012 |